Altogether, our study provides evidence to suggest that HIV-1 Tat might be exerting neurotoxic effects via dysregulating Shh signaling and pharmacological modulation of this signaling may provide beneficial outcomes to control incidences and severity of HAND in HIV-infected population. The gene discussed is SHH; the disease is HIV-associated neurocognitive disorder.